Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070)
South Korea · Delayed Price · Currency is KRW 4,300.00
+20.00 (0.47%)
At close: Jul 9, 2026
Seoulin Bioscience Market Cap
Seoulin Bioscience has a market cap or net worth of 41.09 billion as of July 10, 2026. Its market cap has decreased by -40.68% in one year.
Market Cap
41.09B
Enterprise Value
19.98B
Revenue
78.58B
Ranking
n/a
PE Ratio
138.86
Stock Price
4,300.00
Market Cap Chart
Since October 25, 2005, Seoulin Bioscience's market cap has decreased from 69.74B to 41.09B, a decrease of -41.08%. That is a compound annual growth rate of -2.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 41.09B | -28.49% |
| Dec 30, 2025 | 57.46B | -6.51% |
| Dec 30, 2024 | 61.46B | -21.97% |
| Dec 28, 2023 | 78.77B | -19.25% |
| Dec 29, 2022 | 97.55B | -44.18% |
| Dec 30, 2021 | 174.75B | 62.58% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dx & Vx | 246.07B |
| 3billion | 187.75B |
| GENINUS | 87.45B |
| Cytogen | 71.86B |
| Inventera | 65.60B |
| GC Medical Science | 61.20B |
| Protia | 53.06B |
| HLB Panagene | 50.54B |